Cargando…
Is dyslipidemia associated to mortality in patients with COVID-19?
BACKGROUND: The COVID-19 pandemic has affected millions of people worldwide, so it is necessary to determine risk factors associated with severe disease and mortality, to make a risk stratification for the appropriate use of hospital resources. Except for a few cases, most deaths from this disease a...
Autores principales: | Grecia, Celis, Guillermo, Arauz, Eduardo, Camey, Alejandra, Cárcamo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556495/ http://dx.doi.org/10.1016/j.ahj.2021.10.029 |
Ejemplares similares
-
Cardio-metabolic factors associated to mortality in patients with COVID-19
por: Eduardo, Camey, et al.
Publicado: (2022) -
High Glucose Variability Increases Mortality Risk in Patients with COVID-19
por: Guillermo, Arauz, et al.
Publicado: (2021) -
Lack of significant association between dyslipidemia and COVID-19 mortality
por: Yang, Haiyan, et al.
Publicado: (2021) -
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis
por: Liu, Yanli, et al.
Publicado: (2021) -
Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020)